Skip to main content
. 2018 Nov 8;12:3825–3845. doi: 10.2147/DDDT.S183527

Figure 2.

Figure 2

(A) Forest plot of the decreased forced expiratory volume percentage (FEV1%) between the macrolides group and the placebo group. (B) Forest plot of subgroup analysis of FEV1% by the duration of macrolides. (C) Forest plot of the decreased forced expiratory flow (FEF) 25%–75% between the macrolides group and the placebo group.